3-Bromo-4-(cyclopropylmethoxy)pyridine, 97%, 250mg

Benzamide, N-[2-[(3S)-3-[[4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]cyclohexyl]amino]-1-pyrrolidinyl]-2-oxoethyl]-3-(trifluoromethyl)-, 98%, 100mg

N-butyl-N-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide, 98.0%, 5g

Sample tub ROTILABO® fluoroplastics, 25 ml, 1 Piece

Cinnamaldehyde, min. 98%, for synthesis, 250 ml, glass packaging

Sample stands ROTILABO® for 1.5 ml reaction vials, 5 Piece(s)

H-Hyp(tBu)-OH, 95%, 1g

8-AMINO-1,4-DIOXASPIRO[4.5]DECANE-8-CARBOXYLIC ACID, 95.0%, 1g

tert-Butyl (trans-3-(hydroxymethyl)cyclobutyl)carbamate, 95.0%, 10g

(R)-2-((tert-Butoxycarbonyl)amino)-6-(2,2,2-trifluoroacetamido)hexanoic acid, 95.0%, 5g

(S)-3-Aminohex-5-ynoic acid hydrochloride, 95.0%, 25mg

6-Formylnicotinic acid, 98%, 1g

Pyrimidine-4,5,6-triamine, 95.0%, 5g